Kan Gong

20PUBLICATIONS
21CO-AUTHORS
Cancer diagnosisCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 13, 2026
Development of a Novel 68Ga-Labeled Radiotracer Targeting Carbonic Anhydrase IX for the Diagnosis of Clear Cell Renal Cell Carcinoma.

|Apr 01, 2026
Glucocorticoids elevate clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation.

Kenan Zhang, Lin He, Yizhou Wang

|Mar 19, 2026
Comparison of clinical characteristics between patients with single mutation and co-mutation in hereditary renal cancer: a retrospective analysis of 115 patients with von Hippel-Lindau syndrome.

Tao Liu, Haode Liu, Ruiyi Deng

|Feb 10, 2026
Artificial intelligence-derived transition zone PSA density as a triage tool to reduce unnecessary prostate systematic biopsies in MRI-negative men.

Jiaheng Shang, Jingyun Wu, Ruiyi Deng

|Dec 21, 2024
The long-term survival outcome of sporadic bilateral renal cell carcinoma and optimization of surgical treatment: a large-scale population-based cohort study.

Ruiyi Deng, Jianhui Qiu, Jiaheng Shang

|Nov 13, 2024
Comparison of MRI artificial intelligence-guided cognitive fusion-targeted biopsy versus routine cognitive fusion-targeted prostate biopsy in prostate cancer diagnosis: a randomized controlled trial.

Ruiyi Deng, Yi Liu, Kexin Wang

Pageof 4

Frequent Collaborators

6 joint publications

Jingcheng Zhou

3 joint publications

Wuping Yang

2 joint publications

Haibiao Xie

2 joint publications

Zedan Zhang